ArticleJACC. Asia2026

Phase 3, Open-Label Multicenter Study of Sotatercept in Japanese Participants With Pulmonary Arterial Hypertension.

Hiromi Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.